On the public citation graph

MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma

https://doi.org/10.1016/j.jconrel.2015.04.002
0 signed · 225 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/978-1-60327-553-8_12openalex-snapshot
The Murine GL261 Glioma Experimental Model to Assess Novel Brain Tumor Treatments
inferredcites →https://doi.org/10.1016/j.bbcan.2009.03.003openalex-snapshot
Rho GTPase function in tumorigenesis
inferredcites →https://doi.org/10.1016/j.bbrc.2009.06.034openalex-snapshot
MicroRNA involvement in glioblastoma pathogenesis
inferredcites →https://doi.org/10.1016/j.biomaterials.2011.10.071openalex-snapshot
Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI
inferredcites →https://doi.org/10.1016/j.biomaterials.2013.10.064openalex-snapshot
Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma
inferredcites →https://doi.org/10.1016/j.canlet.2013.08.043openalex-snapshot
Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas
inferredcites →https://doi.org/10.1016/j.febslet.2011.08.014openalex-snapshot
miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells
inferredcites →https://doi.org/10.1016/j.mam.2012.02.003openalex-snapshot
The disturbed blood–brain barrier in human glioblastoma
inferredcites →https://doi.org/10.1023/a:1013884426692openalex-snapshot
The expression of Rho proteins decreases with human brain tumor progression: Potential tumor markers
inferredcites →https://doi.org/10.1038/mtna.2013.30openalex-snapshot
Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment
inferredcites →https://doi.org/10.1038/nature04688openalex-snapshot
RNAi-mediated gene silencing in non-human primates
inferredcites →https://doi.org/10.1038/nature05901openalex-snapshot
Transvascular delivery of small interfering RNA to the central nervous system
inferredcites →https://doi.org/10.1038/nmeth.2019openalex-snapshot
Fiji: an open-source platform for biological-image analysis
inferredcites →https://doi.org/10.1038/nrc1840openalex-snapshot
Oncomirs — microRNAs with a role in cancer
inferredcites →https://doi.org/10.1038/nrc1997openalex-snapshot
MicroRNA signatures in human cancers
inferredcites →https://doi.org/10.1038/sj.onc.1210083openalex-snapshot
miR-21-mediated tumor growth
inferredcites →https://doi.org/10.1038/sj.onc.1211027openalex-snapshot
Regulation of glioblastoma cell invasion by PKCι and RhoB
inferredcites →https://doi.org/10.1053/j.gastro.2007.05.022openalex-snapshot
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
inferredcites →https://doi.org/10.1056/nejmra0708126openalex-snapshot
Malignant Gliomas in Adults
inferredcites →https://doi.org/10.1073/pnas.0510565103openalex-snapshot
A microRNA expression signature of human solid tumors defines cancer gene targets
inferredcites →https://doi.org/10.1088/0957-4484/24/40/405101openalex-snapshot
Tumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomes
inferredcites →https://doi.org/10.1093/hmg/dds496openalex-snapshot
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma
inferredcites →https://doi.org/10.1101/gad.1596707openalex-snapshot
Malignant astrocytic glioma: genetics, biology, and paths to treatment
inferredcites →https://doi.org/10.1152/ajpcell.00025.2004openalex-snapshot
Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1
inferredcites →https://doi.org/10.1158/0008-5472.can-07-1045openalex-snapshot
MicroRNA-21 Knockdown Disrupts Glioma Growth In vivo and Displays Synergistic Cytotoxicity with Neural Precursor Cell–Delivered S-TRAIL in Human Gliomas
inferredcites →https://doi.org/10.1158/0008-5472.can-08-1305openalex-snapshot
MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
inferredcites →https://doi.org/10.1158/0008-5472.can-10-3568openalex-snapshot
Human Glioma Growth Is Controlled by MicroRNA-10b
inferredcites →https://doi.org/10.1158/0008-5472.can-12-4318openalex-snapshot
miR-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma
inferredcites →https://doi.org/10.1161/circresaha.111.247916openalex-snapshot
Developing MicroRNA Therapeutics
inferredcites →https://doi.org/10.1172/jci37515openalex-snapshot
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
inferredcites →https://doi.org/10.1172/jci46039openalex-snapshot
A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration
inferredcites →https://doi.org/10.1215/15228517-2008-072openalex-snapshot
Sagopilone crosses the blood–brain barrier in vivo to inhibit brain tumor growth and metastases
inferredcites →https://doi.org/10.1371/journal.pone.0013879openalex-snapshot
Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8
inferredcites →https://doi.org/10.1371/journal.pone.0047449openalex-snapshot
Silencing of MicroRNA-21 Confers Radio-Sensitivity through Inhibition of the PI3K/AKT Pathway and Enhancing Autophagy in Malignant Glioma Cell Lines
inferredcites →https://doi.org/10.1371/journal.pone.0080865openalex-snapshot
microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models
inferredcites →https://doi.org/10.1371/journal.pone.0084146openalex-snapshot
Disturbing miR-182 and -381 Inhibits BRD7 Transcription and Glioma Growth by Directly Targeting LRRC4
inferredcites →https://doi.org/10.1517/17425247.4.2.175openalex-snapshot
Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601)
inferredcites →https://doi.org/10.3389/fgene.2012.00120openalex-snapshot
miR-34 – a microRNA replacement therapy is headed to the clinic
inferredcites →https://doi.org/10.3892/ijo.2012.1542openalex-snapshot
Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4657914openalex-extracted
Delivery of Rna Drugs: Beyond the Liver, More than Vaccine
inferred← citeshttps://doi.org/10.1002/adtp.202300388openalex-snapshot
Clinical and Translational Opportunities of Nanocarriers Containing RNAi for the Management of Triple‐Negative Breast Cancer
inferred← citeshttps://doi.org/10.1002/bip.22748openalex-snapshot
Chlorotoxin: Structure, activity, and potential uses in cancer therapy
inferred← citeshttps://doi.org/10.1002/cam4.775openalex-snapshot
MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
inferred← citeshttps://doi.org/10.1002/cbic.202400239openalex-snapshot
Gold Nanoparticle Delivery of Glut1 SiRNA Facilitates Glucose Starvation Therapy in Lung Cancer
inferred← citeshttps://doi.org/10.1002/cmdc.201500381openalex-snapshot
pH‐Cleavable Nucleoside Lipids: A New Paradigm for Controlling the Stability of Lipid‐Based Delivery Systems
inferred← citeshttps://doi.org/10.1002/jcp.26029openalex-snapshot
Nanoparticles as new tools for inhibition of cancer angiogenesis
inferred← citeshttps://doi.org/10.1002/jcp.27445openalex-snapshot
The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis
inferred← citeshttps://doi.org/10.1002/smll.201502554openalex-snapshot
Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain
inferred← citeshttps://doi.org/10.1002/smll.201701921openalex-snapshot
Drug Delivery to the Brain across the Blood–Brain Barrier Using Nanomaterials
inferred← citeshttps://doi.org/10.1002/wrna.1662openalex-snapshot
microRNA ‐based diagnostic and therapeutic applications in cancer medicine
inferred← citeshttps://doi.org/10.1007/978-1-4939-3588-8_13openalex-snapshot
Liposomes in Apoptosis Induction and Cancer Therapy
inferred← citeshttps://doi.org/10.1007/978-1-4939-7595-2_27openalex-snapshot
Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-50287-4_26openalex-snapshot
Cancer Nanomedicine: Special Focus on Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-88071-2_5openalex-snapshot
Targeting Cancer by Using Nanoparticles to Modulate RHO GTPase Signaling
inferred← citeshttps://doi.org/10.1007/978-3-032-08824-6_18openalex-snapshot
MicroRNAs Involved in the Regulation of Critical Genes and Their Relevance in the Theragnostics of HPV-Driven Cervical Cancer
inferred← citeshttps://doi.org/10.1007/978-981-13-1568-8_4openalex-snapshot
RNome in Cancer Therapy
inferred← citeshttps://doi.org/10.1007/s00109-019-01798-6openalex-snapshot
The protean world of non-coding RNAs in glioblastoma
inferred← citeshttps://doi.org/10.1007/s00210-025-03934-1openalex-snapshot
Natural compounds as regulators of miRNAs: exploring a new avenue for treating brain cancer
inferred← citeshttps://doi.org/10.1007/s10456-017-9545-xopenalex-snapshot
miRNAs: micro-managers of anticancer combination therapies
inferred← citeshttps://doi.org/10.1007/s10585-019-09966-1openalex-snapshot
The extracellular matrix in tumor progression and metastasis
inferred← citeshttps://doi.org/10.1007/s11033-021-06635-zopenalex-snapshot
Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting
inferred← citeshttps://doi.org/10.1007/s12672-024-01341-1openalex-snapshot
The application of nanoparticles in delivering small RNAs for cancer therapy
inferred← citeshttps://doi.org/10.1007/s13311-017-0524-0openalex-snapshot
Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications
inferred← citeshttps://doi.org/10.1007/s13311-018-00702-3openalex-snapshot
Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
inferred← citeshttps://doi.org/10.1007/s13346-020-00779-4openalex-snapshot
Simultaneous delivery of anti-miRNA and docetaxel with supramolecular self-assembled “chitosome” for improving chemosensitivity of triple negative breast cancer cells
inferred← citeshttps://doi.org/10.1007/s40291-018-0378-0openalex-snapshot
Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring
inferred← citeshttps://doi.org/10.1007/s41061-017-0138-3openalex-snapshot
Brain-Targeted Polymers for Gene Delivery in the Treatment of Brain Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-803581-8.09288-2openalex-snapshot
4.30 Nanomaterials for Drug Delivery to the Brain
inferred← citeshttps://doi.org/10.1016/b978-0-12-804402-5.00004-2openalex-snapshot
Methodological Challenges in Functional Investigation and Therapeutic Use of microRNAs
inferred← citeshttps://doi.org/10.1016/b978-0-12-813667-6.00007-3openalex-snapshot
Brain targeting with lipidic nanocarriers
inferred← citeshttps://doi.org/10.1016/b978-0-12-815669-8.00010-5openalex-snapshot
MicroRNA therapeutics in glioblastoma: Candidates and targeting strategies
inferred← citeshttps://doi.org/10.1016/b978-0-12-819666-3.00005-5openalex-snapshot
Tailoring drug and gene codelivery nanosystems for glioblastoma treatment
inferred← citeshttps://doi.org/10.1016/b978-0-12-821595-1.00013-0openalex-snapshot
Combinatorial RNA therapies in cancer immunotherapy: Challenges and directions
inferred← citeshttps://doi.org/10.1016/b978-0-323-85873-1.00015-0openalex-snapshot
Combination of anticancer drugs with microRNA as cancer therapeutics
inferred← citeshttps://doi.org/10.1016/b978-0-323-90773-6.00006-3openalex-snapshot
Liposomes in drug targeting to brain tumors
inferred← citeshttps://doi.org/10.1016/b978-0-323-99873-4.00029-3openalex-snapshot
An overview of current drug delivery strategies for glioblastoma treatment and barriers to progress
inferred← citeshttps://doi.org/10.1016/bs.ircmb.2017.03.002openalex-snapshot
MicroRNAs as Multifaceted Players in Glioblastoma Multiforme
inferred← citeshttps://doi.org/10.1016/bs.irn.2016.05.002openalex-snapshot
Recent Trends in Nanotechnology Toward CNS Diseases
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114257openalex-snapshot
Advances in nanoparticle mediated targeting of RNA binding protein for cancer
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114415openalex-snapshot
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment
inferred← citeshttps://doi.org/10.1016/j.apsb.2016.05.013openalex-snapshot
Progress and perspectives on targeting nanoparticles for brain drug delivery
inferred← citeshttps://doi.org/10.1016/j.bbrc.2015.05.001openalex-snapshot
TGF-β induced miR-132 enhances the activation of TGF-β signaling through inhibiting SMAD7 expression in glioma cells
inferred← citeshttps://doi.org/10.1016/j.bbrc.2025.152512openalex-snapshot
RNA drugs and nonviral nanocarriers in oncology – present status and emerging concepts
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2016.03.003openalex-snapshot
Development of bioactive materials for glioblastoma therapy
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2023.11.007openalex-snapshot
Engineered smart materials for RNA based molecular therapy to treat Glioblastoma
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2021.121036openalex-snapshot
Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy
inferred← citeshttps://doi.org/10.1016/j.biopha.2015.07.029openalex-snapshot
MiR-454 inhibited cell proliferation of human glioblastoma cells by suppressing PDK1 expression
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2017.03.002openalex-snapshot
Nanocarriers for microRNA delivery in cancer medicine
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2021.107769openalex-snapshot
Recent developments in animal venom peptide nanotherapeutics with improved selectivity for cancer cells
inferred← citeshttps://doi.org/10.1016/j.canlet.2017.05.025openalex-snapshot
microRNA inhibitors: Natural and artificial sequestration of microRNA
inferred← citeshttps://doi.org/10.1016/j.canlet.2020.11.004openalex-snapshot
Targeted delivery of small noncoding RNA for glioblastoma
inferred← citeshttps://doi.org/10.1016/j.coph.2015.09.001openalex-snapshot
Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.10.014openalex-snapshot
miRNA nanotherapeutics for cancer
inferred← citeshttps://doi.org/10.1016/j.ejpb.2016.08.014openalex-snapshot
A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapy
inferred← citeshttps://doi.org/10.1016/j.ejpb.2018.04.018openalex-snapshot
Non-viral based miR delivery and recent developments
inferred← citeshttps://doi.org/10.1016/j.ejpb.2024.114203openalex-snapshot
Recent trends in the delivery of RNA drugs: Beyond the liver, more than vaccine
inferred← citeshttps://doi.org/10.1016/j.ejphar.2022.175388openalex-snapshot
MicroRNA-based therapy for glioblastoma: Opportunities and challenges
inferred← citeshttps://doi.org/10.1016/j.ejphar.2023.175956openalex-snapshot
Development of microRNA-based therapeutics for central nervous system diseases
inferred← citeshttps://doi.org/10.1016/j.heliyon.2021.e07994openalex-snapshot
Lipid nanostructures for targeting brain cancer
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e18626openalex-snapshot
Exosomal non-coding RNAs in angiogenesis: Functions, mechanisms and potential clinical applications
inferred← citeshttps://doi.org/10.1016/j.ijcard.2016.11.263openalex-snapshot
MicroRNA-98 plays a critical role in experimental myocarditis
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2025.126193openalex-snapshot
Targeting with toxins: an overview of venom peptides in drug delivery
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.112116openalex-snapshot
A comprehensive review of miR-21 in liver disease: Big impact of little things
inferred← citeshttps://doi.org/10.1016/j.jare.2023.01.005openalex-snapshot
Antisense-oligonucleotide co-micelles with tumor targeting peptides elicit therapeutic effects by inhibiting microRNA-21 in the glioblastoma animal models
inferred← citeshttps://doi.org/10.1016/j.jchromb.2018.05.050openalex-snapshot
Development of a novel conjugatable sunitinib analogue validated through in vitro and in vivo preclinical settings
inferred← citeshttps://doi.org/10.1016/j.jconrel.2015.09.067openalex-snapshot
Novel delivery approaches for cancer therapeutics
inferred← citeshttps://doi.org/10.1016/j.jconrel.2016.12.017openalex-snapshot
Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy
inferred← citeshttps://doi.org/10.1016/j.jconrel.2017.07.009openalex-snapshot
Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors
inferred← citeshttps://doi.org/10.1016/j.jconrel.2018.05.008openalex-snapshot
Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment
inferred← citeshttps://doi.org/10.1016/j.jconrel.2019.03.015openalex-snapshot
Threatening cancer with nanoparticle aided combination oncotherapy
inferred← citeshttps://doi.org/10.1016/j.jconrel.2019.10.007openalex-snapshot
MicroRNA delivery through nanoparticles
inferred← citeshttps://doi.org/10.1016/j.jconrel.2019.11.010openalex-snapshot
Encapsulated microRNA by gemcitabine prodrug for cancer treatment
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.07.027openalex-snapshot
MicroRNA delivery systems in glioma therapy and perspectives: A systematic review
inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.11.039openalex-snapshot
Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomide
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.114472openalex-snapshot
Enhancing lipid nanoparticles-mediated RNA delivery to glioblastoma via targeted strategies
inferred← citeshttps://doi.org/10.1016/j.jddst.2023.104466openalex-snapshot
Tailor-made nanocargoes as promising tool for brain targeting: Modulated approaches with better therapeutic outcomes
inferred← citeshttps://doi.org/10.1016/j.jtice.2017.04.034openalex-snapshot
Recent advances in the treatment of glioblastoma multiforme by inhibiting angiogenesis and using nanocarrier systems
inferred← citeshttps://doi.org/10.1016/j.lfs.2017.08.027openalex-snapshot
RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials
inferred← citeshttps://doi.org/10.1016/j.lfs.2018.03.044openalex-snapshot
Nanoparticles designed to regulate tumor microenvironment for cancer therapy
inferred← citeshttps://doi.org/10.1016/j.mtbio.2024.101393openalex-snapshot
Magnetic field-induced synergistic therapy of cancer using magnetoplasmonic nanoplatform
inferred← citeshttps://doi.org/10.1016/j.nanoso.2025.101516openalex-snapshot
Advanced miRNA-nanoparticle strategies for brain cancer treatment: Bypass the blood-brain barrier for efficient treatment
inferred← citeshttps://doi.org/10.1016/j.ncrna.2023.10.002openalex-snapshot
Methods of miRNA delivery and possibilities of their application in neuro-oncology
inferred← citeshttps://doi.org/10.1016/j.omtn.2019.09.029openalex-snapshot
Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2024.108762openalex-snapshot
Recent advances in development and delivery of non-viral nucleic acid therapeutics for brain tumor therapy
inferred← citeshttps://doi.org/10.1016/j.phrs.2022.106441openalex-snapshot
Nucleic acid therapy in pediatric cancer
inferred← citeshttps://doi.org/10.1016/j.prp.2023.154591openalex-snapshot
Angiogenesis and prostate cancer: MicroRNAs comes into view
inferred← citeshttps://doi.org/10.1016/j.semcancer.2017.03.005openalex-snapshot
microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies
inferred← citeshttps://doi.org/10.1016/j.semcancer.2020.04.001openalex-snapshot
Targeted delivery of miRNA based therapeuticals in the clinical management of Glioblastoma Multiforme
inferred← citeshttps://doi.org/10.1016/j.snb.2018.09.058openalex-snapshot
Ligation-promoted hyperbranched rolling circle amplification enables ultrasensitive detection of microRNA in clinical specimens
inferred← citeshttps://doi.org/10.1016/j.tibtech.2016.12.009openalex-snapshot
Will Nanotechnology Bring New Hope for Gene Delivery?
inferred← citeshttps://doi.org/10.1016/j.tranon.2018.12.004openalex-snapshot
Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells
inferred← citeshttps://doi.org/10.1017/erm.2023.10openalex-snapshot
New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.4c00293openalex-snapshot
Lipid Nanoparticles for Brain Tumor Theranostics: Challenges and Status
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.6b00999openalex-snapshot
Dual-Function Polymeric HPMA Prodrugs for the Delivery of miRNA
inferred← citeshttps://doi.org/10.1021/acsami.0c03873openalex-snapshot
In Situ Formation of Nanotheranostics to Overcome the Blood–Brain Barrier and Enhance Treatment of Orthotopic Glioma
inferred← citeshttps://doi.org/10.1021/acsami.6b08153openalex-snapshot
Gemcitabine and Antisense-microRNA Co-encapsulated PLGA–PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy
inferred← citeshttps://doi.org/10.1021/acsami.7b19797openalex-snapshot
pH-Responsive Magnetic Mesoporous Silica-Based Nanoplatform for Synergistic Photodynamic Therapy/Chemotherapy
inferred← citeshttps://doi.org/10.1021/acsami.8b06642openalex-snapshot
Polyamino Acid Layer-by-Layer (LbL) Constructed Silica-Supported Mesoporous Titania Nanocarriers for Stimuli-Responsive Delivery of microRNA 708 and Paclitaxel for Combined Chemotherapy
inferred← citeshttps://doi.org/10.1021/acsnano.8b07948openalex-snapshot
RNA Micelles for the Systemic Delivery of Anti-miRNA for Cancer Targeting and Inhibition without Ligand
inferred← citeshttps://doi.org/10.1038/s41386-022-01311-7openalex-snapshot
Nanoparticle delivery systems for substance use disorder
inferred← citeshttps://doi.org/10.1039/9781788015714-00151openalex-snapshot
Research and Development of Oligonucleotides Targeting MicroRNAs (miRNAs)
inferred← citeshttps://doi.org/10.1039/c7bm01088eopenalex-snapshot
A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model
inferred← citeshttps://doi.org/10.1039/c8nr04106gopenalex-snapshot
A graphene-based fluorescent nanoprobe for simultaneous monitoring of miRNA and mRNA in living cells
inferred← citeshttps://doi.org/10.1039/c8tb02946fopenalex-snapshot
Non-viral nanocarriers for intracellular delivery of microRNA therapeutics
inferred← citeshttps://doi.org/10.1039/d0bm01278eopenalex-snapshot
Revisiting gene delivery to the brain: silencing and editing
inferred← citeshttps://doi.org/10.1080/03639045.2016.1200069openalex-snapshot
Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells
inferred← citeshttps://doi.org/10.1080/03639045.2017.1391835openalex-snapshot
Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells
inferred← citeshttps://doi.org/10.1080/08820139.2024.2337022openalex-snapshot
GBM Immunotherapy: Macrophage Impacts
inferred← citeshttps://doi.org/10.1080/08830185.2022.2101647openalex-snapshot
Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds
inferred← citeshttps://doi.org/10.1080/1061186x.2018.1533556openalex-snapshot
Targeting central nervous system pathologies with nanomedicines
inferred← citeshttps://doi.org/10.1080/1120009x.2020.1713508openalex-snapshot
Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology
inferred← citeshttps://doi.org/10.1080/17435889.2025.2492542openalex-snapshot
MicroRNA-targeted nanoparticle delivery systems for cancer therapy: current status and future prospects
inferred← citeshttps://doi.org/10.1080/17435889.2025.2598338openalex-snapshot
Engineered extracellular vesicles for nose-to-brain co-delivery of chlorotoxin and curcumin for treatment of glioblastoma
inferred← citeshttps://doi.org/10.1088/1361-6528/aa527bopenalex-snapshot
Microfluidic chip based micro RNA detection through the combination of fluorescence and surface enhanced Raman scattering techniques
inferred← citeshttps://doi.org/10.1093/hmg/ddab011openalex-snapshot
Differentiation of glioblastoma stem cells promoted by miR-128 or miR-302a overexpression enhances senescence-associated cytotoxicity of axitinib
inferred← citeshttps://doi.org/10.1093/hmg/ddx323openalex-snapshot
High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors
inferred← citeshttps://doi.org/10.1093/hmg/ddz099openalex-snapshot
MiR-144 overexpression as a promising therapeutic strategy to overcome glioblastoma cell invasiveness and resistance to chemotherapy
inferred← citeshttps://doi.org/10.1111/jcmm.17883openalex-snapshot
Silencing of the MEG3 gene promoted anti‐cancer activity and drug sensitivity in glioma
inferred← citeshttps://doi.org/10.1155/2022/5123933openalex-snapshot
Effect of Parecoxib Sodium Combined with Dexmedetomidine on Analgesia and Postoperative Pain of Patients Undergoing Hysteromyomectomy
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-25-0329openalex-snapshot
Translating Venom to Medicine: A Comprehensive Review on the Role of Chlorotoxin in Glioblastoma Diagnosis and Therapy
inferred← citeshttps://doi.org/10.1186/s12935-018-0596-xopenalex-snapshot
Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
inferred← citeshttps://doi.org/10.1186/s40001-022-00833-6openalex-snapshot
Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process
inferred← citeshttps://doi.org/10.1201/9781003119326openalex-snapshot
Nanoparticles for Brain Drug Delivery
inferred← citeshttps://doi.org/10.13023/etd.2016.051openalex-snapshot
Thermodynamics and Kinetics of the Three-Way Junction of Phi29 Motor pRNA and its Assembly into Nanoparticles for Therapeutic Delivery to Prostate Cancer
inferred← citeshttps://doi.org/10.1371/journal.pone.0196929openalex-snapshot
Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models
inferred← citeshttps://doi.org/10.1515/ntrev-2023-0158openalex-snapshot
Cell type-targeting nanoparticles in treating central nervous system diseases: Challenges and hopes
inferred← citeshttps://doi.org/10.1515/revneuro-2024-0086openalex-snapshot
Recent advances on brain drug delivery via nanoparticles: alternative future materials for neuroscience applications; a review
inferred← citeshttps://doi.org/10.18632/oncotarget.16000openalex-snapshot
Micro RNA-98 suppresses interleukin-10 in peripheral B cells in patient post-cardio transplantation
inferred← citeshttps://doi.org/10.18632/oncotarget.18723openalex-snapshot
Micro RNA-155 plays a critical role in the initiation of food allergen-related inflammation in the intestine
inferred← citeshttps://doi.org/10.18632/oncotarget.28039openalex-snapshot
Role of microRNAs in glioblastoma
inferred← citeshttps://doi.org/10.19080/ctbeb.2018.16.555945openalex-snapshot
Use of Animal Venom Peptides/Toxins in Cancer Therapeutics
inferred← citeshttps://doi.org/10.19080/ctbeb.2018.16.555945.openalex-snapshot
Use of Animal Venom Peptides/Toxins in Cancer Therapeutics
inferred← citeshttps://doi.org/10.20892/j.issn.2095-3941.2021.0294openalex-snapshot
Modulating microRNAs in cancer: Next-generation therapies
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1955226/v1openalex-snapshot
Silencing of MEG3 gene promoted anti-cancer activity and drug sensitivity in glioma
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1955226/v2openalex-snapshot
Silencing of MEG3 gene promoted anti-cancer activity and drug sensitivity in glioma
inferred← citeshttps://doi.org/10.2147/ijn.s117210openalex-snapshot
Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier
inferred← citeshttps://doi.org/10.2147/ijn.s90524openalex-snapshot
pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery
inferred← citeshttps://doi.org/10.2147/mnm.s65143openalex-snapshot
Matrix metalloproteinase protein inhibitors: highlighting a new beginning for metalloproteinases in medicine
inferred← citeshttps://doi.org/10.2174/1566523221666210224110454openalex-snapshot
The Effectiveness of Nanoparticles on Gene Therapy for Glioblastoma Cells Apoptosis: A Systematic Review
inferred← citeshttps://doi.org/10.2217/nnm-2017-0223openalex-snapshot
Use of Nanoparticles for Glioblastoma Treatment: a New Approach
inferred← citeshttps://doi.org/10.2217/nnm-2017-0230openalex-snapshot
Nanoparticle/siRNA-based Therapy Strategies in Glioma: Which nanoparticles, Which siRNAs?
inferred← citeshttps://doi.org/10.2217/nnm-2017-0260openalex-snapshot
Multiplexed Nanomedicine for Brain Tumors: Nanosized Hercules to Tame Our Lernaean Hydra inside?
inferred← citeshttps://doi.org/10.22270/jddt.v15i8.7336openalex-snapshot
Biogenesis and implication of miRNAs in the development of diseases and their theranostic inhibitions
inferred← citeshttps://doi.org/10.30895/2221-996x-2024-24-2-140-156openalex-snapshot
miRNA-targeting oligonucleotide constructs with various mechanisms of action as effective inhibitors of carcinogenesis
inferred← citeshttps://doi.org/10.3389/adar.2022.10807openalex-snapshot
Noncoding RNA therapeutics for substance use disorder
inferred← citeshttps://doi.org/10.3389/fbioe.2022.1037051openalex-snapshot
mRNA therapy for myocardial infarction: A review of targets and delivery vehicles
inferred← citeshttps://doi.org/10.3389/fcell.2021.716462openalex-snapshot
Roles of Non-coding RNAs and Angiogenesis in Glioblastoma
inferred← citeshttps://doi.org/10.3389/fmedt.2020.602236openalex-snapshot
Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain
inferred← citeshttps://doi.org/10.3389/fnmol.2021.621831openalex-snapshot
Current Approaches for Glioma Gene Therapy and Virotherapy
inferred← citeshttps://doi.org/10.3389/fonc.2021.705634openalex-snapshot
MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
inferred← citeshttps://doi.org/10.3389/fphar.2019.00488openalex-snapshot
Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics
inferred← citeshttps://doi.org/10.3390/cancers13071526openalex-snapshot
microRNAs as Novel Therapeutics in Cancer
inferred← citeshttps://doi.org/10.3390/cancers13205192openalex-snapshot
Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma
inferred← citeshttps://doi.org/10.3390/cancers15133388openalex-snapshot
Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles
inferred← citeshttps://doi.org/10.3390/ijms18020350openalex-snapshot
AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells
inferred← citeshttps://doi.org/10.3390/ijms20010103openalex-snapshot
Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme
inferred← citeshttps://doi.org/10.3390/ijms20174123openalex-snapshot
MicroRNA Signature in Human Normal and Tumoral Neural Stem Cells
inferred← citeshttps://doi.org/10.3390/ijms20246126openalex-snapshot
Lab-On-A-Chip for the Development of Pro-/Anti-Angiogenic Nanomedicines to Treat Brain Diseases
inferred← citeshttps://doi.org/10.3390/ijms21041495openalex-snapshot
Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines
inferred← citeshttps://doi.org/10.3390/ijms21124490openalex-snapshot
Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations
inferred← citeshttps://doi.org/10.3390/ijms21145039openalex-snapshot
Combinatory Treatment with miR-7-5p and Drug-Loaded Cubosomes Effectively Impairs Cancer Cells
inferred← citeshttps://doi.org/10.3390/ijms21165631openalex-snapshot
Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance
inferred← citeshttps://doi.org/10.3390/ijms21165732openalex-snapshot
Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach
inferred← citeshttps://doi.org/10.3390/ijms21249630openalex-snapshot
MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies
inferred← citeshttps://doi.org/10.3390/ijms22042210openalex-snapshot
Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment
inferred← citeshttps://doi.org/10.3390/ijms23084153openalex-snapshot
Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology
inferred← citeshttps://doi.org/10.3390/ijms24043521openalex-snapshot
microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review
inferred← citeshttps://doi.org/10.3390/molecules25215006openalex-snapshot
Lipid-Nucleic Acid Complexes: Physicochemical Aspects and Prospects for Cancer Treatment
inferred← citeshttps://doi.org/10.3390/nano6070131openalex-snapshot
Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer
inferred← citeshttps://doi.org/10.3390/pharmaceutics14040768openalex-snapshot
Dual-Functional Polymeric Micelles Co-Loaded with Antineoplastic Drugs and Tyrosine Kinase Inhibitor for Combination Therapy in Colorectal Cancer
inferred← citeshttps://doi.org/10.3390/pharmaceutics16040494openalex-snapshot
Preparation and Optimization of MiR-375 Nano-Vector Using Two Novel Chitosan-Coated Nano-Structured Lipid Carriers as Gene Therapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/vaccines10091448openalex-snapshot
Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms
inferred← citeshttps://doi.org/10.3892/mmr.2017.8063openalex-snapshot
miR‑218 inhibits the proliferation of human glioma cells through downregulation of Yin Yang 1
inferred← citeshttps://doi.org/10.3892/ol.2019.10276openalex-snapshot
lncRNA‑NEF is downregulated in osteosarcoma and inhibits cancer cell migration and invasion by downregulating miRNA‑21
inferred← citeshttps://doi.org/10.4103/2395-3977.155924openalex-snapshot
Systematic Review of MicroRNAs and its Therapeutic Potential in Glioma
inferred← citeshttps://doi.org/10.4103/ijnpnd.ijnpnd_72_23openalex-snapshot
An Overview of Various Approaches for Brain Targeted Drug Delivery System
inferred← citeshttps://doi.org/10.4155/fmc.15.108openalex-snapshot
Enhancing the Pharmacokinetic/Pharmacodynamic Properties of Therapeutic Nucleotides Using Lipid Nanoparticle Systems
inferred← citeshttps://doi.org/10.4155/tde-2020-0052openalex-snapshot
Progress in Systemic Co-Delivery of microRNAs and Chemotherapeutics for Cancer Treatment by using Lipid-Based Nanoparticles
inferred← citeshttps://doi.org/10.5772/intechopen.108386openalex-snapshot
MicroRNA Biomarkers in Primary Brain Malignancies
inferred← citeshttps://doi.org/10.5772/intechopen.76922openalex-snapshot
Multifunctional Nanoparticles for Successful Targeted Drug Delivery across the Blood-Brain Barrier
inferred← citeshttps://doi.org/10.5772/intechopen.83040openalex-snapshot
Nanopharmaceuticals: A Boon to the Brain-Targeted Drug Delivery
inferred← citeshttps://doi.org/10.5772/intechopen.94151openalex-snapshot
Regulation of Angiogenesis Using Nanomaterial Based Formulations: An Emerging Therapeutic Strategy to Manage Multiple Pathological Conditions
inferred← citeshttps://doi.org/10.7150/thno.38261openalex-snapshot
Advances in nanomedicine for cancer starvation therapy
inferred← citeshttps://doi.org/10.7150/thno.56936openalex-snapshot
An “eat me” combinatory nano-formulation for systemic immunotherapy of solid tumors
inferred← citeshttps://doi.org/10.7497/j.issn.2095-3941.2015.0020openalex-snapshot
Development of targeted therapies in treatment of glioblastoma.
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.